195.84
price down icon1.64%   -2.87
 
loading

Becton Dickinson Co Borsa (BDX) Ultime notizie

pulisher
07:37 AM

BD Launches Next Generation Hemodynamic Monitoring Solution Providing Clinicians with AI-Driven Clinical Decision Support - marketscreener.com

07:37 AM
pulisher
07:35 AM

Becton, Dickinson and Company Launches Next Generation Hemodynamic Monitoring Solution Providing Clinicians with Ai-Driven Clinical Decision Support - marketscreener.com

07:35 AM
pulisher
07:14 AM

BD warns on intravascular catheter - MassDevice

07:14 AM
pulisher
Apr 16, 2025

Is Becton, Dickinson and Company (BDX) the Best Dividend Monarch to Invest in Now? - Insider Monkey

Apr 16, 2025
pulisher
Apr 16, 2025

Is Becton Dickinson Gaining or Losing Market Support? - Benzinga

Apr 16, 2025
pulisher
Apr 16, 2025

Global In-Vitro Diagnostics Market Predicted to Surpass the USD 90 Billion Mark by 2032 | DelveInsight - GlobeNewswire Inc.

Apr 16, 2025
pulisher
Apr 16, 2025

As historic trial starts in Covington, medical devoce sterilizer defends ‘safe and responsible’ operations - AJC.com

Apr 16, 2025
pulisher
Apr 16, 2025

Becton, Dickinson and Co. : Leading Industry Analyst Amit Bhalla Joins BD as Vice President, Global Strategy and Development - marketscreener.com

Apr 16, 2025
pulisher
Apr 13, 2025

​Becton Dickinson in talks with Thermo Fisher, Danaher to divest life sciences unit, FT reports - MSN

Apr 13, 2025
pulisher
Apr 12, 2025

Barclays Has Lowered Expectations for Becton, Dickinson and Company (NYSE:BDX) Stock Price - MarketBeat

Apr 12, 2025
pulisher
Apr 11, 2025

Retired truck driver contends emissions from ethylene oxide caused his cancer - AJC.com

Apr 11, 2025
pulisher
Apr 11, 2025

BD to acquire Bard - The Covington News

Apr 11, 2025
pulisher
Apr 11, 2025

Becton, Dickinson and Co. : BD Appoints Christopher Reidy as Chief Financial Officer - marketscreener.com

Apr 11, 2025
pulisher
Apr 10, 2025

Becton Dickinson EVP Michael Garrison sells $94,497 in stock - Investing.com Australia

Apr 10, 2025
pulisher
Apr 10, 2025

Becton Dickinson EVP Michael Garrison sells $94,497 in stock By Investing.com - Investing.com Canada

Apr 10, 2025
pulisher
Apr 09, 2025

Becton Dickinson and : BD Receives FDA 510(k) Clearance for Advanced Microbiology Solution - MarketScreener

Apr 09, 2025
pulisher
Apr 08, 2025

Becton Dickinson's SWOT analysis: med tech giant's stock poised for growth - Investing.com

Apr 08, 2025
pulisher
Apr 08, 2025

BD Seeks Potential Buyers for Life Sciences Business Division - Yahoo Finance

Apr 08, 2025
pulisher
Apr 07, 2025

Citigroup Adjusts Becton Dickinson and Co. Price Target to $270 From $275, Maintains Buy Rating - MarketScreener

Apr 07, 2025
pulisher
Apr 04, 2025

Becton, Dickinson Becomes Oversold - Nasdaq

Apr 04, 2025
pulisher
Apr 04, 2025

Should You be Confident in Becton, Dickinson and Company’s (BDX) Ability to Deliver Long-Term Returns? - Yahoo

Apr 04, 2025
pulisher
Apr 04, 2025

BD reports pay increases for some execs, decreases for others - Medical Design & Outsourcing

Apr 04, 2025
pulisher
Apr 03, 2025

BD to Announce Financial Results for its Second Quarter of Fiscal 2025 - Quantisnow

Apr 03, 2025
pulisher
Apr 03, 2025

Vascular Access Device Market Growth is Driven by Ongoing Research and Development in the Industry, Key Players -Becton, Dickinson and Company, - Global Banking | Finance | Review

Apr 03, 2025
pulisher
Apr 01, 2025

Report: BD is in talks with competitors to sell Life Sciences biz - MassDevice

Apr 01, 2025
pulisher
Apr 01, 2025

Becton Dickinson in talks with Thermo Fisher, Danaher to divest life sciences unit, FT reports - MarketScreener

Apr 01, 2025
pulisher
Apr 01, 2025

Becton Dickinson in talks to divest life sciences unit, FT reports - MarketScreener

Apr 01, 2025
pulisher
Apr 01, 2025

Becton Dickinson In Talks With Rivals Over Divesting Life Sciences Unit- FT - marketscreener.com

Apr 01, 2025
pulisher
Apr 01, 2025

Becton Dickinson in talks with rivals over divesting life sciences unit - Financial Times

Apr 01, 2025
pulisher
Mar 31, 2025

BD Named One of America's Most Innovative Companies by Fortune - Quantisnow

Mar 31, 2025
pulisher
Mar 30, 2025

Becton Dickinson Could Be Cure To Demand For Medtech Supplies, With Robust Pipeline - Seeking Alpha

Mar 30, 2025
pulisher
Mar 28, 2025

Here’s What Positions Becton, Dickinson and Company (BDX) Favorably in the Health Care Sector - Yahoo Finance

Mar 28, 2025
pulisher
Mar 27, 2025

BD Names Gregory J. Hayes to Board of Directors :: Becton, Dickinson and Company (BDX) - Becton Dickinson

Mar 27, 2025
pulisher
Mar 27, 2025

BD Names Gregory J. Hayes to Board of Directors - Quantisnow

Mar 27, 2025
pulisher
Mar 27, 2025

BD Names Gregory J. Hayes to Board of Directors – Company Announcement - Financial Times

Mar 27, 2025
pulisher
Mar 27, 2025

Goldman Sachs Adjusts PT on Becton Dickinson and Co. to $256 From $253, Keeps Buy Rating - Marketscreener.com

Mar 27, 2025
pulisher
Mar 27, 2025

Goldman Sachs Adjusts PT to Becton Dickinson and Co. to $256 From $253, Keeps Buy Rating - marketscreener.com

Mar 27, 2025
pulisher
Mar 22, 2025

Was Jim Cramer Right About Becton, Dickinson and Company (BDX)? - Insider Monkey

Mar 22, 2025
pulisher
Mar 22, 2025

Insider Sell: Richard Byrd Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus.com

Mar 22, 2025
pulisher
Mar 21, 2025

FDA tags Becton, Dickinson and Company infusion software recall as Class I - Yahoo Finance

Mar 21, 2025
pulisher
Mar 21, 2025

Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term - Yahoo Finance

Mar 21, 2025
pulisher
Mar 20, 2025

Becton Dickinson and : BD Announces Results for 2019 Second Fiscal Quarter; Updates Fiscal 2019 Guidance - MarketScreener

Mar 20, 2025
pulisher
Mar 20, 2025

Becton, Dickinson Treats First Breast Revision Patient in GalaFlex Lite Scaffold Trial -March 20, 2025 at 07:56 am EDT - MarketScreener

Mar 20, 2025
pulisher
Mar 20, 2025

BD Announces Milestone in Clinical Trial for Use of Bioabsorbable GalaFLEX LITE™ Scaffold in Breast Implant Revision Surgery - Quantisnow

Mar 20, 2025
pulisher
Mar 20, 2025

Becton, Dickinson and Company Announces Milestone in Clinical Trial for Use of Bioabsorbable GalaFLEX LITE? Scaffold in Breast Implant Revision Surgery - Marketscreener.com

Mar 20, 2025
pulisher
Mar 20, 2025

Correction: Software for Alaris Systems Manager and CCE Adapter - fda.gov

Mar 20, 2025
medical_instruments_supplies ALC
$92.94
price up icon 0.16%
medical_instruments_supplies RMD
$211.90
price down icon 0.68%
medical_instruments_supplies COO
$78.49
price down icon 1.26%
medical_instruments_supplies WST
$202.15
price up icon 0.58%
medical_instruments_supplies BAX
$28.60
price down icon 1.11%
Capitalizzazione:     |  Volume (24 ore):